• News
  • SAN DIEGO
  • Finance

Dexcom gains FDA approval; stocks rise

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
60.55
  0.67  
+ 1.12%
547,226,000
64.64
28.09

Insider Trade Data

Date Insider Shares Type Value
02/24/2015 Balo, Andrew K 7,500 Exchange $73,500
02/18/2015 Roper, Jess 7,000 Sell $433,192
02/18/2015 Roper, Jess 6,000 Exchange $45,780
02/17/2015 Gregg, Terrance H 15,000 Sell $932,802
02/17/2015 Moy, Jeffrey C 5,044 Sell $313,291

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!